Oluwaseun Johnson-Akeju, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 24 | 2024 | 1695 | 3.820 |
Why?
|
Ketamine | 13 | 2024 | 524 | 2.590 |
Why?
|
Dexmedetomidine | 11 | 2023 | 320 | 2.280 |
Why?
|
Electroencephalography | 32 | 2024 | 6317 | 1.940 |
Why?
|
Propofol | 10 | 2023 | 608 | 1.770 |
Why?
|
Hypnotics and Sedatives | 13 | 2021 | 1188 | 1.520 |
Why?
|
Anesthetics, Inhalation | 7 | 2020 | 573 | 1.450 |
Why?
|
Anesthesia, General | 11 | 2020 | 1186 | 1.450 |
Why?
|
Cardiac Surgical Procedures | 9 | 2024 | 3681 | 1.120 |
Why?
|
Neuroglia | 6 | 2019 | 960 | 0.860 |
Why?
|
Anesthetics, Intravenous | 4 | 2017 | 397 | 0.810 |
Why?
|
Brain | 22 | 2023 | 27452 | 0.760 |
Why?
|
Brain Waves | 4 | 2021 | 418 | 0.740 |
Why?
|
Methyl Ethers | 4 | 2019 | 196 | 0.730 |
Why?
|
Anesthetics, Dissociative | 2 | 2021 | 80 | 0.720 |
Why?
|
Intensive Care Units | 12 | 2023 | 3800 | 0.700 |
Why?
|
Consciousness | 4 | 2019 | 602 | 0.660 |
Why?
|
Sleep | 14 | 2024 | 4802 | 0.660 |
Why?
|
Receptors, GABA | 9 | 2023 | 313 | 0.630 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 3 | 2018 | 93 | 0.620 |
Why?
|
Respiratory Insufficiency | 3 | 2023 | 1241 | 0.620 |
Why?
|
Arousal | 4 | 2018 | 1183 | 0.620 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2024 | 452 | 0.600 |
Why?
|
Sleep Stages | 4 | 2020 | 705 | 0.590 |
Why?
|
Cardiopulmonary Bypass | 4 | 2021 | 1097 | 0.580 |
Why?
|
Migraine with Aura | 2 | 2020 | 204 | 0.570 |
Why?
|
Anesthesia | 6 | 2020 | 1596 | 0.520 |
Why?
|
Fentanyl | 2 | 2020 | 450 | 0.520 |
Why?
|
Nitric Oxide | 3 | 2024 | 2143 | 0.500 |
Why?
|
Malnutrition | 2 | 2022 | 631 | 0.480 |
Why?
|
Sleep Apnea Syndromes | 2 | 2022 | 982 | 0.440 |
Why?
|
Isoflurane | 2 | 2017 | 384 | 0.440 |
Why?
|
Electrocardiography | 5 | 2021 | 6409 | 0.440 |
Why?
|
Low Back Pain | 2 | 2022 | 989 | 0.420 |
Why?
|
Endocannabinoids | 1 | 2023 | 113 | 0.410 |
Why?
|
Humans | 111 | 2024 | 768298 | 0.410 |
Why?
|
Heart Rate | 5 | 2021 | 4218 | 0.400 |
Why?
|
Unconsciousness | 4 | 2020 | 251 | 0.390 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2024 | 905 | 0.380 |
Why?
|
Positron-Emission Tomography | 12 | 2023 | 6670 | 0.360 |
Why?
|
Monitoring, Intraoperative | 2 | 2018 | 950 | 0.350 |
Why?
|
Macaca | 1 | 2021 | 417 | 0.340 |
Why?
|
Sulfonic Acids | 1 | 2020 | 102 | 0.340 |
Why?
|
Persian Gulf Syndrome | 1 | 2020 | 48 | 0.330 |
Why?
|
Antidepressive Agents | 4 | 2023 | 2913 | 0.330 |
Why?
|
Confusion | 1 | 2022 | 278 | 0.330 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2020 | 115 | 0.330 |
Why?
|
Rest | 2 | 2023 | 951 | 0.330 |
Why?
|
Preoptic Area | 1 | 2020 | 132 | 0.320 |
Why?
|
Periodicity | 1 | 2020 | 348 | 0.320 |
Why?
|
Dementia | 3 | 2023 | 2728 | 0.320 |
Why?
|
Anesthetics | 3 | 2018 | 525 | 0.310 |
Why?
|
Meninges | 1 | 2020 | 197 | 0.310 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 277 | 0.300 |
Why?
|
Respiration, Artificial | 6 | 2023 | 2721 | 0.300 |
Why?
|
Adult | 45 | 2024 | 223622 | 0.300 |
Why?
|
Carbamazepine | 1 | 2019 | 224 | 0.300 |
Why?
|
Anesthesiology | 2 | 2024 | 1137 | 0.300 |
Why?
|
Anesthetics, General | 2 | 2017 | 152 | 0.300 |
Why?
|
Respiration | 2 | 2021 | 1667 | 0.290 |
Why?
|
Anesthesia Recovery Period | 1 | 2018 | 155 | 0.290 |
Why?
|
Osteoarthritis, Knee | 2 | 2023 | 1252 | 0.290 |
Why?
|
Postoperative Complications | 10 | 2024 | 15854 | 0.280 |
Why?
|
Acetamides | 2 | 2018 | 260 | 0.280 |
Why?
|
Suicidal Ideation | 2 | 2018 | 1461 | 0.280 |
Why?
|
Analgesics | 2 | 2021 | 1070 | 0.280 |
Why?
|
Aged | 34 | 2024 | 171544 | 0.280 |
Why?
|
Male | 53 | 2024 | 364870 | 0.280 |
Why?
|
Deep Sedation | 1 | 2018 | 119 | 0.270 |
Why?
|
Pyridines | 4 | 2018 | 2889 | 0.270 |
Why?
|
Dopamine | 1 | 2023 | 1617 | 0.260 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 59 | 0.260 |
Why?
|
Critical Care | 3 | 2020 | 2716 | 0.260 |
Why?
|
Research Personnel | 1 | 2021 | 590 | 0.260 |
Why?
|
Nutritional Status | 2 | 2022 | 1627 | 0.260 |
Why?
|
Education, Distance | 1 | 2019 | 261 | 0.260 |
Why?
|
Administration, Inhalation | 3 | 2024 | 1169 | 0.250 |
Why?
|
Nerve Net | 3 | 2018 | 2362 | 0.250 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 470 | 0.250 |
Why?
|
Forearm | 1 | 2018 | 428 | 0.250 |
Why?
|
Middle Aged | 36 | 2024 | 223463 | 0.240 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 782 | 0.240 |
Why?
|
Female | 50 | 2024 | 397050 | 0.240 |
Why?
|
Encephalitis | 1 | 2019 | 441 | 0.240 |
Why?
|
Locus Coeruleus | 1 | 2017 | 243 | 0.240 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2016 | 1473 | 0.240 |
Why?
|
Critical Illness | 4 | 2021 | 2755 | 0.240 |
Why?
|
Delta Rhythm | 1 | 2015 | 82 | 0.240 |
Why?
|
Nitrous Oxide | 1 | 2015 | 166 | 0.230 |
Why?
|
Neuronal Plasticity | 2 | 2017 | 1448 | 0.230 |
Why?
|
Polysomnography | 4 | 2022 | 1865 | 0.230 |
Why?
|
Anesthesia, Inhalation | 1 | 2015 | 220 | 0.230 |
Why?
|
Brain Diseases | 2 | 2022 | 1552 | 0.230 |
Why?
|
Motor Neurons | 2 | 2016 | 872 | 0.230 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 709 | 0.230 |
Why?
|
Embryoid Bodies | 1 | 2014 | 65 | 0.220 |
Why?
|
Fibromyalgia | 1 | 2018 | 406 | 0.220 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1175 | 0.220 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3836 | 0.210 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3241 | 0.210 |
Why?
|
Orthopedics | 1 | 2022 | 906 | 0.210 |
Why?
|
Cerebral Cortex | 3 | 2023 | 5830 | 0.210 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1099 | 0.200 |
Why?
|
Frail Elderly | 3 | 2023 | 775 | 0.200 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1794 | 0.200 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.200 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1891 | 0.190 |
Why?
|
Receptors, GABA-A | 1 | 2016 | 625 | 0.190 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1280 | 0.190 |
Why?
|
Prospective Studies | 12 | 2024 | 54921 | 0.180 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8747 | 0.180 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1482 | 0.180 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1496 | 0.180 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1402 | 0.180 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2018 | 1039 | 0.180 |
Why?
|
Neural Pathways | 3 | 2017 | 3121 | 0.170 |
Why?
|
Vitamin D | 1 | 2024 | 3311 | 0.170 |
Why?
|
Pain Measurement | 1 | 2020 | 3579 | 0.170 |
Why?
|
Pandemics | 4 | 2023 | 8750 | 0.170 |
Why?
|
Retrospective Studies | 15 | 2024 | 81768 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 9063 | 0.170 |
Why?
|
Depressive Disorder, Major | 2 | 2018 | 4819 | 0.170 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 756 | 0.170 |
Why?
|
Geriatric Assessment | 3 | 2022 | 1422 | 0.170 |
Why?
|
Young Adult | 14 | 2021 | 60048 | 0.160 |
Why?
|
Embryonic Development | 1 | 2014 | 722 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 10776 | 0.160 |
Why?
|
Patient Care Team | 1 | 2020 | 2529 | 0.160 |
Why?
|
Motor Cortex | 1 | 2016 | 1014 | 0.160 |
Why?
|
Anticonvulsants | 1 | 2019 | 1923 | 0.160 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 537 | 0.150 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2513 | 0.150 |
Why?
|
Thalamus | 1 | 2014 | 1050 | 0.150 |
Why?
|
Guideline Adherence | 1 | 2018 | 2240 | 0.150 |
Why?
|
Hospitalization | 3 | 2023 | 10844 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 10 | 2022 | 36849 | 0.140 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2097 | 0.140 |
Why?
|
Circadian Rhythm | 2 | 2023 | 2588 | 0.140 |
Why?
|
Aging | 4 | 2023 | 8764 | 0.140 |
Why?
|
Patient Discharge | 2 | 2024 | 3474 | 0.130 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5890 | 0.130 |
Why?
|
Veterans | 1 | 2020 | 2672 | 0.130 |
Why?
|
Administration, Oral | 3 | 2020 | 4043 | 0.130 |
Why?
|
Neurons | 3 | 2020 | 9512 | 0.130 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 567 | 0.130 |
Why?
|
Time Factors | 7 | 2023 | 40267 | 0.120 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1516 | 0.120 |
Why?
|
Age Factors | 4 | 2020 | 18472 | 0.120 |
Why?
|
Exercise | 1 | 2021 | 5947 | 0.120 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2734 | 0.120 |
Why?
|
Hypertension | 2 | 2022 | 8615 | 0.120 |
Why?
|
Brain Mapping | 2 | 2017 | 6740 | 0.110 |
Why?
|
Kinetics | 2 | 2024 | 6334 | 0.110 |
Why?
|
Neurotoxicity Syndromes | 1 | 2017 | 302 | 0.110 |
Why?
|
Mitochondria, Heart | 1 | 2004 | 236 | 0.110 |
Why?
|
Thalamic Nuclei | 1 | 2023 | 111 | 0.110 |
Why?
|
Institutionalization | 1 | 2023 | 108 | 0.110 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 26373 | 0.110 |
Why?
|
Stroke | 2 | 2020 | 9742 | 0.100 |
Why?
|
Physicians | 1 | 2021 | 4614 | 0.100 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2023 | 137 | 0.100 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.100 |
Why?
|
N-Methylaspartate | 1 | 2023 | 231 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1601 | 0.100 |
Why?
|
Inflammation | 2 | 2023 | 10863 | 0.100 |
Why?
|
Nucleic Acid Conformation | 1 | 2006 | 900 | 0.100 |
Why?
|
Neurophysiology | 1 | 2023 | 145 | 0.100 |
Why?
|
Risk Factors | 7 | 2024 | 74954 | 0.100 |
Why?
|
Brain Injuries | 1 | 2013 | 2059 | 0.100 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 2226 | 0.100 |
Why?
|
Adolescent | 10 | 2020 | 89182 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2537 | 0.090 |
Why?
|
Astrocytes | 2 | 2020 | 1349 | 0.090 |
Why?
|
Nursing Homes | 2 | 2024 | 1084 | 0.090 |
Why?
|
Pilot Projects | 3 | 2020 | 8730 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2020 | 12457 | 0.090 |
Why?
|
Glycolysis | 1 | 2004 | 838 | 0.090 |
Why?
|
Pyridostigmine Bromide | 1 | 2020 | 32 | 0.090 |
Why?
|
Gulf War | 1 | 2020 | 33 | 0.090 |
Why?
|
Respiratory Rate | 1 | 2021 | 180 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2023 | 1585 | 0.080 |
Why?
|
Animals | 10 | 2024 | 169322 | 0.080 |
Why?
|
Algorithms | 3 | 2021 | 14154 | 0.080 |
Why?
|
Choline | 1 | 2021 | 518 | 0.080 |
Why?
|
Hyperalgesia | 1 | 2023 | 527 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4859 | 0.080 |
Why?
|
Creatine | 1 | 2021 | 427 | 0.080 |
Why?
|
Actigraphy | 1 | 2023 | 526 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 21544 | 0.080 |
Why?
|
Aspartic Acid | 1 | 2021 | 577 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2007 | 1356 | 0.080 |
Why?
|
Drug Synergism | 2 | 2017 | 1760 | 0.080 |
Why?
|
Organizational Objectives | 1 | 2020 | 426 | 0.080 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.080 |
Why?
|
Cohort Studies | 4 | 2024 | 41791 | 0.070 |
Why?
|
Coma | 1 | 2021 | 487 | 0.070 |
Why?
|
Half-Life | 1 | 2019 | 650 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2006 | 2038 | 0.070 |
Why?
|
Hospitals | 2 | 2022 | 3905 | 0.070 |
Why?
|
Length of Stay | 2 | 2022 | 6516 | 0.070 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 310 | 0.070 |
Why?
|
Markov Chains | 1 | 2021 | 977 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2021 | 740 | 0.070 |
Why?
|
Nitrosourea Compounds | 1 | 2007 | 32 | 0.070 |
Why?
|
Beta Rhythm | 1 | 2017 | 65 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2018 | 6034 | 0.070 |
Why?
|
Models, Animal | 1 | 2023 | 2124 | 0.070 |
Why?
|
Stathmin | 1 | 2007 | 70 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3436 | 0.070 |
Why?
|
Sensation | 1 | 2018 | 337 | 0.070 |
Why?
|
Comorbidity | 2 | 2022 | 10588 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2024 | 1406 | 0.070 |
Why?
|
Cortical Spreading Depression | 1 | 2020 | 288 | 0.070 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 188 | 0.070 |
Why?
|
Patients | 1 | 2023 | 909 | 0.070 |
Why?
|
Inhibitory Postsynaptic Potentials | 1 | 2016 | 62 | 0.060 |
Why?
|
Probability | 1 | 2021 | 2482 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2007 | 2986 | 0.060 |
Why?
|
Models, Neurological | 1 | 2024 | 1783 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2022 | 3412 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2022 | 22292 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59683 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2020 | 700 | 0.060 |
Why?
|
Theta Rhythm | 1 | 2017 | 222 | 0.060 |
Why?
|
Skull | 1 | 2020 | 831 | 0.060 |
Why?
|
Oligodendroglioma | 1 | 2007 | 278 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.060 |
Why?
|
HIV Infections | 1 | 2022 | 17575 | 0.060 |
Why?
|
Morbidity | 1 | 2020 | 1758 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 997 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15652 | 0.060 |
Why?
|
Indoles | 1 | 2023 | 1825 | 0.060 |
Why?
|
Prevalence | 2 | 2022 | 15868 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2007 | 640 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2019 | 2298 | 0.060 |
Why?
|
Area Under Curve | 1 | 2019 | 1642 | 0.060 |
Why?
|
Hypothalamus | 1 | 2020 | 1005 | 0.060 |
Why?
|
Safety Management | 1 | 2020 | 765 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2024 | 1389 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2106 | 0.060 |
Why?
|
Drug Interactions | 1 | 2019 | 1420 | 0.060 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.060 |
Why?
|
Alpha Rhythm | 1 | 2014 | 112 | 0.060 |
Why?
|
Program Development | 1 | 2020 | 1298 | 0.060 |
Why?
|
Dizocilpine Maleate | 1 | 2014 | 173 | 0.060 |
Why?
|
Reference Standards | 1 | 2017 | 1013 | 0.060 |
Why?
|
Thrombectomy | 1 | 2018 | 671 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 30020 | 0.050 |
Why?
|
Hypothermia | 1 | 2015 | 188 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2023 | 2661 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.050 |
Why?
|
Work of Breathing | 1 | 2022 | 57 | 0.050 |
Why?
|
Survival Rate | 2 | 2021 | 12870 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 7074 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2018 | 1058 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5802 | 0.050 |
Why?
|
New York City | 1 | 2024 | 737 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1174 | 0.050 |
Why?
|
Glioblastoma | 1 | 2007 | 3526 | 0.050 |
Why?
|
Behavior | 1 | 2014 | 543 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5168 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2201 | 0.050 |
Why?
|
Myocardium | 1 | 2004 | 4788 | 0.050 |
Why?
|
Myoblasts, Cardiac | 1 | 2011 | 21 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 371 | 0.050 |
Why?
|
tau Proteins | 1 | 2022 | 2142 | 0.050 |
Why?
|
Proteomics | 2 | 2021 | 3906 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2007 | 9197 | 0.050 |
Why?
|
Ventilator Weaning | 1 | 2022 | 170 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2783 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2014 | 753 | 0.050 |
Why?
|
Pain | 2 | 2023 | 5102 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2023 | 500 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1664 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3781 | 0.050 |
Why?
|
Noise | 1 | 2023 | 292 | 0.050 |
Why?
|
Perioperative Care | 1 | 2018 | 1045 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1795 | 0.040 |
Why?
|
Outpatients | 1 | 2018 | 1603 | 0.040 |
Why?
|
Remission Induction | 1 | 2016 | 2407 | 0.040 |
Why?
|
Cause of Death | 1 | 2021 | 3728 | 0.040 |
Why?
|
Hemodynamics | 1 | 2020 | 4199 | 0.040 |
Why?
|
Pyrimidines | 2 | 2017 | 3048 | 0.040 |
Why?
|
Independent Living | 1 | 2024 | 580 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11515 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2024 | 406 | 0.040 |
Why?
|
Rats | 2 | 2020 | 23833 | 0.040 |
Why?
|
Occupational Exposure | 1 | 2020 | 1817 | 0.040 |
Why?
|
Mortality | 1 | 2021 | 2917 | 0.040 |
Why?
|
Oxygen | 1 | 2021 | 4273 | 0.040 |
Why?
|
Mice | 3 | 2023 | 82004 | 0.040 |
Why?
|
Microglia | 1 | 2018 | 1374 | 0.040 |
Why?
|
Life Style | 1 | 2021 | 3930 | 0.040 |
Why?
|
Seizures | 1 | 2022 | 3000 | 0.040 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1143 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8198 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1674 | 0.040 |
Why?
|
Electrophysiology | 1 | 2011 | 1266 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1226 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2015 | 2727 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2022 | 5367 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39405 | 0.040 |
Why?
|
Okadaic Acid | 1 | 2007 | 67 | 0.040 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2007 | 28 | 0.040 |
Why?
|
Massachusetts | 1 | 2020 | 8902 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18358 | 0.030 |
Why?
|
Databases, Factual | 1 | 2022 | 8072 | 0.030 |
Why?
|
Psychometrics | 1 | 2016 | 3069 | 0.030 |
Why?
|
Odds Ratio | 1 | 2018 | 9681 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2426 | 0.030 |
Why?
|
Knee Joint | 1 | 2023 | 1686 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2708 | 0.030 |
Why?
|
Clinical Competence | 1 | 2020 | 4847 | 0.030 |
Why?
|
Boston | 1 | 2017 | 9371 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2011 | 808 | 0.030 |
Why?
|
Infant | 2 | 2017 | 36512 | 0.030 |
Why?
|
Electron Transport | 1 | 2004 | 211 | 0.030 |
Why?
|
Tretinoin | 1 | 2007 | 524 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15939 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2014 | 5898 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 1281 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1283 | 0.030 |
Why?
|
Child, Preschool | 2 | 2017 | 42654 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2014 | 11659 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 501 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2004 | 913 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15455 | 0.020 |
Why?
|
Glioma | 1 | 2007 | 3526 | 0.020 |
Why?
|
Warfarin | 1 | 2020 | 1493 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5335 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10377 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4414 | 0.020 |
Why?
|
Base Sequence | 2 | 2007 | 12421 | 0.020 |
Why?
|
Protein Transport | 1 | 2007 | 1958 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7861 | 0.020 |
Why?
|
Attention | 1 | 2020 | 2425 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2007 | 6132 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2363 | 0.020 |
Why?
|
Child | 2 | 2017 | 80894 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2017 | 65365 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 282 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2681 | 0.020 |
Why?
|
Phosphorylation | 1 | 2007 | 8326 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9380 | 0.020 |
Why?
|
Epilepsy | 1 | 2020 | 3326 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4842 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2015 | 3230 | 0.010 |
Why?
|
Proteome | 1 | 2004 | 1880 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 749 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2823 | 0.010 |
Why?
|
Pregnancy | 1 | 2014 | 30198 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1748 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10464 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2524 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10656 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 13038 | 0.010 |
Why?
|
Risk Assessment | 1 | 2011 | 24316 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4622 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16027 | 0.010 |
Why?
|
United States | 1 | 2023 | 73144 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17626 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23629 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 17132 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13696 | 0.000 |
Why?
|